Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study

Peer Review reports

Original Submission
17 Feb 2021	Submitted	Original manuscript
24 Oct 2021	Reviewed	Reviewer Report - Gillian Gresham
23 Nov 2021	Author responded	Author comments - Daisuke Hashimoto
Resubmission - Version 2
23 Nov 2021	Submitted	Manuscript version 2
5 Dec 2021	Reviewed	Reviewer Report - Gillian Gresham
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
10 Dec 2021	Editorially accepted
12 Feb 2022	Article published	10.1186/s13063-021-05934-x

Back to article page